Scour Bos 9This page contains information on Scour Bos 9 for veterinary use.
The information provided typically includes the following:
- Scour Bos 9 Indications
- Warnings and cautions for Scour Bos 9
- Direction and dosage information for Scour Bos 9
Scour Bos 9This treatment applies to the following species:
Bovine Rota-Coronavirus Vaccine
Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
For Use In Animals Only
Scour Bos 9 Indications
For use in healthy pregnant cattle as an aid in the prevention of disease in calves caused by bovine rotavirus, bovine coronavirus, Clostridium perfringens Type C, and K99 piliated Escherichia coli.
ADJUVANT: Xtend™ III.
Directions For Use
Shake well before using. Administer 2 mL intramuscularly in the neck 8-16 weeks prior to calving. Revaccinate with (Scour Bos 4) 4 weeks prior to calving. Revaccinate with one dose of (Scour Bos 9) 8-10 weeks prior to each subsequent calving.
PrecautionsStore out of direct sunlight at 2°-8° C (35°-46° F). DO NOT FREEZE. Do not mix with other products, except as specified on the label. In case of human exposure, contact a physician. Use entire contents when first opened. Do not vaccinate within 60 days prior to slaughter. It is essential that newborn calves receive colostrum from the vaccinated dam. WARNING: THIS PRODUCT MAY CAUSE PERSISTENT SWELLING AT THE SITE OF INJECTION. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine. Contains amphotericin B, gentamicin, and thimerosal as preservatives.
Elanco US, Inc., Fort Dodge, IA 50501 USA; 1-800-428-4441
Scour Bos, Xtend, Elanco and the diagonal bar logo are trademarks of Eli Lilly and Company or its affiliates.
Distributed by ELANCO US, INC.
2500 INNOVATION WAY, GREENFIELD, IN, 46140
|Every effort has been made to ensure the accuracy of the Scour Bos 9 information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2021 Animalytix LLC. Updated: 2021-10-04